Related references
Note: Only part of the references are listed.L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
Feng Gao et al.
INTEGRATIVE BIOLOGY (2011)
Apolipoprotein A-I Mimetic Peptides A Potential New Therapy for the Prevention of Atherosclerosis
Courtney B. Sherman et al.
CARDIOLOGY IN REVIEW (2010)
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice
Nosratola D. Vaziri et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
Feng Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors
Daejin Kim et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Apolipoprotein A-I Mimetic Peptides
Brian J. Van Lenten et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Apo A-1 mimetic peptides as atheroprotective agents in murine models
Mohamad Navab et al.
CURRENT DRUG TARGETS (2008)
Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth
Christine J. Weydert et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LeAnne T. Bloedon et al.
JOURNAL OF LIPID RESEARCH (2008)
Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer
Loannis Delimaris et al.
CLINICAL BIOCHEMISTRY (2007)
Long-term treatment with the apoliprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats
Stephen J. Peterson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Oxidative stress and cancer: have we moved forward?
Barry Halliwell
BIOCHEMICAL JOURNAL (2007)
Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth
Christine J. Weydert et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD
Yuping Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Apolipoprotein A-I-mimetic peptides with antioxidant actions
Su Duy Nguyen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Free radicals, metals and antioxidants in oxidative stress-induced cancer
M Valko et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Characterization of serum biomarkers for detection of early stage ovarian cancer
KR Kozak et al.
PROTEOMICS (2005)
Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes
S Turkseven et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes
AL Kruger et al.
CIRCULATION (2005)
Mechanism of the tumor suppressive effect of MnSOD overexpression
LW Oberley
BIOMEDICINE & PHARMACOTHERAPY (2005)
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis
KR Kozak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium:: Potential implications in intracellular fluorescence detection of superoxide
HT Zhao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells
ZJ Ou et al.
CIRCULATION (2003)
Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach
A Horiuchi et al.
GYNECOLOGIC ONCOLOGY (2003)
Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts
M Schimmel et al.
ONCOGENE (2002)